Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

BACKGROUND: Among patients with advanced non-small-cell lung cancer who were treated with nivolumab monotherapy, the association of peripheral blood count data (at baseline and 2 weeks after treatment initiation) with the early onset of immune-related adverse events (irAEs) and treatment efficacy ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Egami, Saeka, Kawazoe, Hitoshi, Hashimoto, Hironobu, Uozumi, Ryuji, Arami, Toko, Sakiyama, Naomi, Ohe, Yuichiro, Nakada, Hideo, Aomori, Tohru, Ikemura, Shinnosuke, Fukunaga, Koichi, Yamaguchi, Masakazu, Nakamura, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190379/
https://www.ncbi.nlm.nih.gov/pubmed/34123782
http://dx.doi.org/10.3389/fonc.2021.618570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190379/
https://www.ncbi.nlm.nih.gov/pubmed/34123782
http://dx.doi.org/10.3389/fonc.2021.618570

Ejemplares similares